Terms: = Gastric cancer AND SND1, Q7KZF4, TDRD11, p100, ENSG00000197157, 27044 AND Treatment
3 results:
1. MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1.
Ma F; Song H; Guo B; Zhang Y; Zheng Y; Lin C; Wu Y; Guan G; Sha R; Zhou Q; Wang D; Zhou X; Li J; Qiu X
Oncotarget; 2015 Jul; 6(19):17404-16. PubMed ID: 25965817
[TBL] [Abstract] [Full Text] [Related]
2. A novel snd1-BRAF fusion confers resistance to c-Met inhibitor PF-04217903 in GTL16 cells through [corrected] MAPK activation.
Lee NV; Lira ME; Pavlicek A; Ye J; Buckman D; Bagrodia S; Srinivasa SP; Zhao Y; Aparicio S; Rejto PA; Christensen JG; Ching KA
PLoS One; 2012; 7(6):e39653. PubMed ID: 22745804
[TBL] [Abstract] [Full Text] [Related]
3. Discovery of a novel B-Raf fusion protein related to c-Met drug resistance.
Dillon R; Nilsson CL; Shi SD; Lee NV; Krastins B; Greig MJ
J Proteome Res; 2011 Nov; 10(11):5084-94. PubMed ID: 21936566
[TBL] [Abstract] [Full Text] [Related]
